| 0000-00-00 |
|
|
|
External link to document |
| 2019-12-22 |
162 |
Redacted Document |
applied
to the patent-in-suit (U.S Patent No. 8,129,385, the “’385 patent”) and related applications…medication infringes two claims of ViiV’s U.S. Patent No. 8,129,385 under
the doctrine of equivalents.
…that the Patent
Office did not really consider the patent-in-suit when granting Gilead’s patent for
…its own
patent over the ’385 patent. These conclusions would apply equally to the patent-
in-suit…the ’385 Patent
and Gilead’s Patent Does Not Bear on Whether the Two Patents Include |
External link to document |
| 2020-02-04 |
174 |
Opinion - Memorandum Opinion |
infringing United States Patent Number
8,129,385 (the #385 patent). The #385 patent covers pharmaceutical…principle of patent law that the claims of a
2
patent define the…requirements for a
patent.") ( citation omitted). It is the claims-not the patent's written description…Bictegravir infringes claims 2 and 6 of the #3 85 patent under the
doctrine of equivalents. That doctrine… literally infringe upon the express terms of a patent claim may nonetheless be
found to infringe if |
External link to document |
| 2020-02-09 |
176 |
Notice of Service |
Dobkin, M.D. Regarding Infringement of U.S. Patent No. 8,129,385; (3) Reply Expert Report of Jennifer Dressman…Guengerich, Ph.D., Regarding Infringement of U.S. Patent No. 8,129,385; (6) Reply Expert Report of Kenneth M. Merz…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385; (7) Supplemental Reply Expert Report of…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385; (8) Expert Report of Timothy Simcoe, Ph.D…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385 filed by Shionogi & Co., Ltd., ViiV Healthcare |
External link to document |
| 2020-04-21 |
235 |
Redacted Document |
claimed embodiment of
claims 2 and 6 of U.S. Patent 8,129,385) and bictegravir (“BIC) sodium (“BIC sodium…claimed embodiment of claims 2
and 6 of U.S. Patent 8,129,385) and bictegravir (“BIC”) are insubstantial…INC.’S INFRINGEMENT OF U.S. PATENT
NO. 8,129,385
…Gilead Sciences, Inc.’s Infringement of U.S. Patent No. 8,129,385 (“Merz
Opening Report”), the February …Gilead Sciences, Inc.’s Infringement of U.S. Patent No. 8,129,385 (“Merz Reply
Report”), and the February |
External link to document |
| 2018-02-06 |
3 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,129,385. (crb) (Entered: …2018
2 February 2022
1:18-cv-00224
830 Patent
Plaintiff
District Court, D. Delaware |
External link to document |
